134 related articles for article (PubMed ID: 20731662)
1. Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo.
Pitchakarn P; Ogawa K; Suzuki S; Takahashi S; Asamoto M; Chewonarin T; Limtrakul P; Shirai T
Cancer Sci; 2010 Oct; 101(10):2234-40. PubMed ID: 20731662
[TBL] [Abstract][Full Text] [Related]
2. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
[TBL] [Abstract][Full Text] [Related]
3. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Cancer Lett; 2011 Jul; 306(2):142-50. PubMed ID: 21429659
[TBL] [Abstract][Full Text] [Related]
4. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
[TBL] [Abstract][Full Text] [Related]
5. Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo.
Yang SF; Chu SC; Liu SJ; Chen YC; Chang YZ; Hsieh YS
J Ethnopharmacol; 2007 Apr; 110(3):483-9. PubMed ID: 17113737
[TBL] [Abstract][Full Text] [Related]
6. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells.
Chu SC; Yang SF; Liu SJ; Kuo WH; Chang YZ; Hsieh YS
Food Chem Toxicol; 2007 Jul; 45(7):1194-201. PubMed ID: 17303298
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Sehgal I; Baley PA; Thompson TC
Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
[TBL] [Abstract][Full Text] [Related]
11. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2008 Mar; 7(1):42-50. PubMed ID: 18292594
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
14. The butanol fraction of guava (Psidium cattleianum Sabine) leaf extract suppresses MMP-2 and MMP-9 expression and activity through the suppression of the ERK1/2 MAPK signaling pathway.
Im I; Park KR; Kim SM; Kim C; Park JH; Nam D; Jang HJ; Shim BS; Ahn KS; Mosaddik A; Sethi G; Cho SK; Ahn KS
Nutr Cancer; 2012; 64(2):255-66. PubMed ID: 22211962
[TBL] [Abstract][Full Text] [Related]
15. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
16. The hexane extract of Saussurea lappa and its active principle, dehydrocostus lactone, inhibit prostate cancer cell migration.
Kim EJ; Hong JE; Lim SS; Kwon GT; Kim J; Kim JS; Lee KW; Park JH
J Med Food; 2012 Jan; 15(1):24-32. PubMed ID: 22082097
[TBL] [Abstract][Full Text] [Related]
17. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
18. Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer.
Thelen P; Scharf JG; Burfeind P; Hemmerlein B; Wuttke W; Spengler B; Christoffel V; Ringert RH; Seidlová-Wuttke D
Carcinogenesis; 2005 Aug; 26(8):1360-7. PubMed ID: 15845653
[TBL] [Abstract][Full Text] [Related]
19. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression.
Choi JH; Han EH; Hwang YP; Choi JM; Choi CY; Chung YC; Seo JK; Jeong HG
Food Chem Toxicol; 2010 Feb; 48(2):564-71. PubMed ID: 19922761
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells.
Sigstedt SC; Hooten CJ; Callewaert MC; Jenkins AR; Romero AE; Pullin MJ; Kornienko A; Lowrey TK; Slambrouck SV; Steelant WF
Int J Oncol; 2008 May; 32(5):1085-90. PubMed ID: 18425335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
